FDA safety update · November 2026

Lose the weight. Keep everything else.

The FDA's new GLP-1 eye warning: what it means for you.

The FDA added a warning about a rare eye condition to every GLP-1. Here's how rare it is, what the evidence shows and the one symptom to know.

Medically reviewed by Mark Nessim, MD, board-certified anesthesiologist · Last updated

Who publishes this: Habthera Nutrition, which makes ASP-1, a protein supplement. Where our product appears it is labeled as ours. Editorial policy.

The short answer

A new warning about a rare eye condition. Not a reason to stop on your own.

On November 9, 2026, the FDA said it is requiring every GLP-1 medicine to add a warning about a possible increased risk of NAION, a rare condition that can cause sudden vision loss, to the Warnings and Precautions section of its label.[1][2] It covers semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), orforglipron (Foundayo) and the older drugs in the class.[2]

It is a label warning, not a recall and not a restriction on who can take these drugs.[3] The practical change for you is one rule: sudden vision loss is an emergency. Get an eye exam the same day.

What NAION is

A stroke of the front of the optic nerve

NAION stands for non-arteritic anterior ischemic optic neuropathy. Blood flow to the front of the optic nerve drops, and the nerve is damaged.[4] It usually affects one eye. The vision loss is typically painless and sudden, and people often notice it on waking. It can be partial, like a shadow over the top or bottom half of the view, and it can be permanent.[5]

It was a known condition long before GLP-1s. The usual risk factors include a small, crowded optic disc, diabetes, high blood pressure, sleep apnea and older age, which overlap heavily with the people most likely to be prescribed a GLP-1. That overlap is one reason the evidence has been hard to read.

What the FDA found

Rare, and the evidence is mixed. The FDA said so itself.

For scale: in 2025, the European Medicines Agency's safety committee classed NAION as a very rare side effect of semaglutide, affecting up to 1 in 10,000 people taking it for at least a year.[4][6]

From our medical reviewer: "A label warning means you and your doctor should know the symptom. It does not mean a drug that is helping you has become unsafe overnight. Keep taking it, and know what sudden vision loss means." Mark Nessim, MD, board-certified anesthesiologist

What to do

If you take a GLP-1

  1. Don't stop your medication because of the headline. Talk to your prescriber at your next visit, or sooner if you have had NAION or other optic nerve disease before. The FDA says people who have had NAION should discuss whether to continue.[5]
  2. Treat sudden vision loss as an emergency. New blurring, a dark or gray area, or loss of the upper or lower half of vision in one eye: same-day eye exam or emergency department. Tell them you take a GLP-1.
  3. Tell your eye doctor you are on a GLP-1 at your next routine exam, especially if you have diabetes.
  4. Treat the risk factors you can. Untreated sleep apnea and uncontrolled blood pressure raise NAION risk on their own. If you snore heavily or wake unrefreshed, ask about a sleep study.

If you're having surgery or sedation

Tell the anesthesia team you take a GLP-1, for the stomach-emptying reasons in our procedure guide. If you have had NAION before, mention that too. It is part of the history an anesthesiologist wants before long or prone-position operations.

Common questions

Did the FDA add a vision warning to Ozempic, Wegovy and Zepbound?

Yes. On November 9, 2026 the FDA required all GLP-1 receptor agonist medicines, including semaglutide, tirzepatide and orforglipron, to add a warning about a potential increased risk of NAION, a rare cause of sudden vision loss, to the Warnings and Precautions section of their labels.

Should I stop my GLP-1 because of the NAION warning?

Do not stop on your own. The warning does not restrict who can take these drugs. Talk to your prescriber, especially if you have had NAION before, and get a same-day eye exam if you notice sudden vision loss.

How common is NAION on a GLP-1?

It is rare. In 2025 the European Medicines Agency estimated it may affect up to 1 in 10,000 people taking semaglutide for at least a year. In the trial data the FDA reviewed, there were 10 probable cases among GLP-1 users and 5 among placebo users across 126 trials.

What are the symptoms of NAION?

Sudden, usually painless vision loss in one eye, often noticed on waking. It can affect the upper or lower half of vision or look like a shadow or blur. It needs a same-day eye exam.

Keep reading

More from Keep Everything Else

Do GLP-1s cause muscle loss?What the 2026 research actually measured, and what protects you.How much protein on a GLP-1The daily target, and how to hit it when you're not hungry.The personalized protein calculatorDaily, per-meal and leucine targets for your size, age and training.The latest GLP-1 research, explainedNew studies and FDA actions each week, labeled by type of evidence.GLP-1 telehealth costs comparedRo, Hims, WeightWatchers, Noom: the real monthly price.New trial: lifting weights on a GLP-125% less muscle loss, and strength went up instead of down.New study: it's the share of you that's muscleA 59,269-person study, and what it means on a GLP-1.Surgery or sedation on a GLP-1What an anesthesiologist wants you to tell them before a procedure.GLP-1 supplements: reading the claimsThe red flags a physician-lawyer looks for on a label.Nausea on a GLP-1Eight habits that help, and the signs that need a doctor.Constipation on a GLP-1What works, in order, and when not to wait.Hair loss on a GLP-1Why it happens, whether it grows back, what helps.Colonoscopy on a GLP-1The prep problem most people haven't heard about.Upper endoscopy on a GLP-1Why your stomach may not be empty, and what to tell the team.Dental sedation on a GLP-1Wisdom teeth and implants: what to tell the office.Plastic surgery after GLP-1 weight lossTiming, anesthesia and healing.What to eat on a GLP-1A protein-first plate and a sample day.GLP-1 protein powders comparedFive products on label facts. We make one of them.Thanksgiving on a GLP-1A plan for the big meal, drinks, doses and travel.FSA and HSA money before Dec 31What it covers on a GLP-1, and the 2026 rules.The free GLP-1 Safety KitPrintable checklists: procedures, protein, side-effect red flags.What a GLP-1 costs in 2026Manufacturer prices, telehealth ranked, and HSA/FSA.